These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 8383219)
1. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. Rose RC; Bonnez W; Reichman RC; Garcea RL J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219 [TBL] [Abstract][Full Text] [Related]
2. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560 [TBL] [Abstract][Full Text] [Related]
3. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960 [TBL] [Abstract][Full Text] [Related]
4. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. Le Cann P; Coursaget P; Iochmann S; Touze A FEMS Microbiol Lett; 1994 Apr; 117(3):269-74. PubMed ID: 8200503 [TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus. Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761 [TBL] [Abstract][Full Text] [Related]
6. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes. Chen Y; Ghim SJ; Jenson AB; Schlegel R J Gen Virol; 1998 Sep; 79 ( Pt 9)():2137-46. PubMed ID: 9747722 [TBL] [Abstract][Full Text] [Related]
7. Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. McCarthy MP; White WI; Palmer-Hill F; Koenig S; Suzich JA J Virol; 1998 Jan; 72(1):32-41. PubMed ID: 9420197 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. Park DS; Selvey LA; Kelsall SR; Frazer IH J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603 [TBL] [Abstract][Full Text] [Related]
9. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908 [TBL] [Abstract][Full Text] [Related]
10. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins. Buonamassa DT; Greer CE; Capo S; Yen TS; Galeotti CL; Bensi G Virology; 2002 Feb; 293(2):335-44. PubMed ID: 11886254 [TBL] [Abstract][Full Text] [Related]
11. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901 [TBL] [Abstract][Full Text] [Related]
12. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products. Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224 [TBL] [Abstract][Full Text] [Related]
13. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer. Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172 [TBL] [Abstract][Full Text] [Related]
14. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus. Nagesha HS; Wang LF; Hyatt AD; Morrissy CJ; Lenghaus C; Westbury HA Arch Virol; 1995; 140(6):1095-1108. PubMed ID: 7541982 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles. Heino P; Dillner J; Schwartz S Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535 [TBL] [Abstract][Full Text] [Related]
16. Generation and neutralization of pseudovirions of human papillomavirus type 33. Unckell F; Streeck RE; Sapp M J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652 [TBL] [Abstract][Full Text] [Related]
17. Immunological analyses of human papillomavirus capsids. Giroglou T; Sapp M; Lane C; Fligge C; Christensen ND; Streeck RE; Rose RC Vaccine; 2001 Feb; 19(13-14):1783-93. PubMed ID: 11166904 [TBL] [Abstract][Full Text] [Related]
18. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749 [TBL] [Abstract][Full Text] [Related]
19. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles. Xu Y; Wang Q; Han Y; Song G; Xu X J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054 [TBL] [Abstract][Full Text] [Related]
20. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]